Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marcin Kubeczko"'
Autor:
Marcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna Świderska, Aleksandra Leśniak, Marta Mianowska-Malec, Barbarba Łanoszka, Konstanty Chomik, Barbara Grandys, Natalya Lisovska, Barbara Bobek-Billewicz, Ewa Chmielik, Michał Jarząb
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCyclin-dependent kinase 4/6 inhibitors (CDK4/6i) represent the gold standard of the hormone receptor positive human epidermal growth factor receptor 2 (HER-2) negative advanced breast cancer. However, optimal treatment after disease progres
Externí odkaz:
https://doaj.org/article/9a4c366505004ce28c0ef2c9cfb629a9
Autor:
Marcin Kubeczko, Dorota Gabryś, Anna Polakiewicz-Gilowska, Barbara Bobek-Billewicz, Michał Jarząb
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 927 (2024)
Background. The use of locoregional radiotherapy (RT) in patients with advanced ER-positive, HER2-negative breast cancer remains a topic of ongoing debate. In this study, we aimed to evaluate the efficacy of locoregional RT in advanced breast cancer
Externí odkaz:
https://doaj.org/article/a6a356455bfc4010aa9722dfc8768f5e
Autor:
Marcin Kubeczko, Anna Michalik, Agnieszka Badora-Rybicka, Anna Polakiewicz-Gilowska, Andrea d'Amico, Michał Kalemba, Aleksandra Leśniak, Katarzyna Świderska, Marta Mianowska-Malec, Agnieszka Pasierbek, Barbara Łanoszka, Konstanty Chomik, Barbara Bobek-Billewicz, Michał Jarząb
Publikováno v:
Cancer Research. 82:P2-12
Introduction. The addition of carboplatin to standard neoadjuvant chemotherapy (NAC) including dose-dense (dd) anthracycline-cyclophosphamide (AC) combination followed by taxanes in triple negative breast cancer (TNBC) is the most intense routinely u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2deb2034b4b1f3294d55779066ac35fd
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07
https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07
Autor:
Marcin Kubeczko, Michał Jarząb, Aleksandra Krzywon, Donata Gräupner, Anna Polakiewicz-Gilowska, Dorota Gabryś
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 5
Pages: 2044
Volume 12
Issue 5
Pages: 2044
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy are the standard of care for HR-positive/HER2-negative advanced breast cancer patients. However, their role in the treatment of brain metastases is currently unclear. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe188f0270d90219cd5c3123053f12a
https://doi.org/10.3390/jcm12052044
https://doi.org/10.3390/jcm12052044
Autor:
Marcin Kubeczko, Dorota Gabryś, Marzena Gawkowska, Anna Polakiewicz-Gilowska, Alexander J. Cortez, Aleksandra Krzywon, Grzegorz Woźniak, Tomasz Latusek, Aleksandra Leśniak, Katarzyna Świderska, Marta Mianowska-Malec, Barbara Łanoszka, Konstanty Chomik, Mateusz Gajek, Anna Michalik, Elżbieta Nowicka, Rafał Tarnawski, Tomasz Rutkowski, Michał Jarząb
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 690
Volume 15
Issue 3
Pages: 690
The addition of CDK4/6 inhibitors to endocrine therapy in advanced hormone receptor-positive HER2-negative breast cancer has led to practice-changing improvements in overall survival. However, data concerning the safety of CDK4/6i combination with ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b3e65a6f0a471b7b6e9c8eddf92737
https://doi.org/10.3390/cancers15030690
https://doi.org/10.3390/cancers15030690
Autor:
Enrique Gallego‑Colon, Kamil Wdowiak, Paulina Czajka‑Francuz, Maciej T. Wybraniec, Tomasz Francuz, Natalia Ruiz‑Agamez, Marcin Kubeczko, Jerzy Chudek, Iga Grochoła, Jerzy Wojnar
Publikováno v:
Oncology Letters
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. Despite improvements in treatment, CLL is still considered an incurable disease. The aim of the present study was to evaluate galectin-1, -3 and -9 (Gal-1, -3 and -9) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ff4052b04174eb446fb1a477a8fa91
http://europepmc.org/articles/PMC6313089
http://europepmc.org/articles/PMC6313089
Autor:
Wojciech Spychałowicz, Elżbieta Nowara, Jerzy Chudek, Jerzy Wojnar, Marcin Kubeczko, Anna Bednarek, Kamil Wdowiak, Dobromiła Karwasiecka
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 70, Pp 534-541 (2016)
Background: Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable prognostic factor in CLL. Curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792ce1b70819c1f61e31a2cc90ad3ac6
http://phmd.pl/gicid/01.3001.0009.6833
http://phmd.pl/gicid/01.3001.0009.6833
Autor:
Joanna Huszno, Katarzyna Swiderska, Jaroslaw Nieckula, Agnieszka Badora-Rybicka, Elżbieta Nowara, Marcin Kubeczko
Publikováno v:
Journal of Tumor. 4:474-477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55b1a5904a1ac1e608d6e07c6a47b18b
https://doi.org/10.17554/j.issn.1819-6187.2016.04.97
https://doi.org/10.17554/j.issn.1819-6187.2016.04.97
Autor:
Marco Di Pietro, Anna Michalik, Anna Polakiewicz-Gilowska, Agnieszka Pasierbek, Rafal Tarnawski, Marcin Kubeczko, Damian Borys, Agnieszka Badora-Rybicka, Andrea d'Amico, Mateusz Raus, Barbara Bobek-Billewicz, Michał Jarząb, Wiesław Bal, Olgierd Chrabański, Izabela Gorczewska
Publikováno v:
Cancer Research. 80:P4-02
Preoperative chemotherapy (preopCT) is gaining importance in management of breast cancer, as it allows to avoid axillary clearance in responders. In case of axillary surgery the pathological complete response (pCR) of involved nodes is required to om
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb80fea3b3bf0c0352672aaa5fd4475c
https://doi.org/10.1158/1538-7445.sabcs19-p4-02-12
https://doi.org/10.1158/1538-7445.sabcs19-p4-02-12
Autor:
Tomasz Francuz, Iga Grochoła, Enrique Gallego-Colon, Marcin Kubeczko, Natalia Ruiz-Agamez, Kamil Wdowiak, Jerzy Wojnar
Publikováno v:
International Journal of Molecular Sciences
The incidence and mortality of cancer have increased over the past decades. Significant progress has been made in understanding the underpinnings of this disease and developing therapies. Despite this, cancer still remains a major therapeutic challen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d318331869588db6d969f99c28f51634
https://pubmed.ncbi.nlm.nih.gov/29320431
https://pubmed.ncbi.nlm.nih.gov/29320431